Gestodene structure, CAS 60282-87-3

Gestodene

CAS Number60282-87-3

Synonyms(17a)-13-Ethyl-17-hydroxy-18,19-dinorpregna-4,15-dien-20-yn-3-one; SH B 331; GESTOGENE; SH B 33; Femodene; EINECS 262-145-8; Gestodene; GESTODONE; 17a-Ethynyl-13-ethyl-17b-hydroxy-4,15-gonadien-3-one; SHG 415 G; 17a-Ethynyl-17b-hydroxy-18-methyl-4,15-estradien-3-one; Gynovin; MFCD00867858

Molecular FormulaC21H26O2

Molecular Weight310.43

Purity98%

Density1.2±0.1 g/cm3

Boiling Point462.7±45.0 °C at 760 mmHg

Melting Point190-192°C

Flash Point

AppearanceWhite crystalline solid

EINECS

MSDSChineseEnglish

SymbolTransport

Signal WordWarning

Cat. No.: 2A-9010720 Purity: 98%
Change View

Please Login or Create an Account to: See VlP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

Quality Control of [ 60282-87-3 ] Purity: 98% SDS Specification MoL

Chemical & Physical Properties
CAS Number60282-87-3
Catalog No.2A-9010720
Chinese Name孕二烯酮
Synonyms(17a)-13-Ethyl-17-hydroxy-18,19-dinorpregna-4,15-dien-20-yn-3-one; SH B 331; GESTOGENE; SH B 33; Femodene; EINECS 262-145-8; Gestodene; GESTODONE; 17a-Ethynyl-13-ethyl-17b-hydroxy-4,15-gonadien-3-one; SHG 415 G; 17a-Ethynyl-17b-hydroxy-18-methyl-4,15-estradien-3-one; Gynovin; MFCD00867858
Molecular FormulaC21H26O2
Molecular Weight310.43
Purity98
Density1.2±0.1 g/cm3
Boiling Point462.7±45.0 °C at 760 mmHg
Melting Point190-192°C
AppearanceWhite crystalline solid
Storage Condition-20°C Freezer
ApplicationGestodene (SHB 331; WL 70) is a progestogen-based contraceptive.
PubChem ID329831269
MDL NumberMFCD00867858
SMILESCC[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@H]34)[C@@H]1C=C[C@@]2(O)C#C
InChI1S/C21H26O2/c1-3-20-11-9-17-16-8-6-15(22)13-14(16)5-7-18(17)19(20)10-12-21(20,23)4-2/h2,10,12-13,16-19,23H,3,5-9,11H2,1H3/t16-,17+,18+,19-,20-,21-/m0/s1
InChI KeySIGSPDASOTUPFS-XUDSTZEESA-N
NACRES CodeNA.24
UNSPSC41116107
Hazard SymbolsTransport
MSDSmsds/10720_1_60282_87_3.pdf
BioactivityGestodene(SHB 331;WL 70) is a progestogen hormonal contraceptive.Target: Estrogen Receptor/ERRGestodene is androgenically neutral, meaning that contraceptive pills containing gestodene do not exhibit the androgenic side effects (e.g. acne, hirsutism, weight gain) often associated with second-generation contraceptive pills, such as those containing levonorgestrel. When 40 micrograms of gestodene was taken, six out of seven women did not ovulate, and one out of seven had a cycle with luteal insufficiency. These data indicate that 40 micrograms of gestodene is the borderline dose for inhibition of ovulation. A combination of 75 micrograms gestodene with 30 micrograms ethinyl estradiol was found to inhibit ovulation in ten subjects, and no follicular maturation was noted [1]. gestodene bound with high affinity to the progesterone receptor, as did other synthetic and natural progestogens. However, gestodene did not bind to the estradiol receptor. The relative binding affinities of all tested synthetic and natural ligands showed no organ-specific differences and no differences between neoplastically transformed and normal tissues [2].Clinical indications: Female contraception Related Catalog Signaling Pathways >> Others >> Progesterone Receptor Research Areas >> Endocrinology References [1]. Spona, J. and J. Huber, Pharmacological and endocrine profiles of gestodene. Int J Fertil, 1987. 32 Suppl: p. 6-14. [2]. Pollow, K., et al., Lack of binding of gestodene to estrogen receptor in human breast cancer tissue. Eur J Cancer, 1990. 26(5): p. 608-10. Chemical & Physical Properties Density 1.2±0.1 g/cm3 Boiling Point 462.7±45.0 °C at 760 mmHg Melting Point 190-192°C Molecular Formula C21H26O2 Molecular Weight 310.430 Flash Point 196.9±21.3 °C Exact Mass 310.193268 PSA 37.30000 LogP 3.65 Vapour Pressure 0.0±2.6 mmHg at 25°C Index of Refraction 1.588 InChIKey SIGSPDASOTUPFS-XUDSTZEESA-N SMILES C#CC1(O)C=CC2C3CCC4=CC(=O)CCC4C3CCC21CC Storage condition -20°C Freezer
Use ofProperties Articles36 Name Gestodene Synonym More Synonyms Gestodene Biological Activity Related Catalog Signaling Pathways >> Others >> Progesterone Receptor Research Areas >> Endocrinology References [1]. Spona, J. and J. Huber, Pharmacological and endocrine profiles of gestodene. Int J Fertil, 1987. 32 Suppl: p. 6-14. [2]. Pollow, K., et al., Lack of binding of gestodene to estrogen receptor in human breast cancer tissue. Eur J Cancer, 1990. 26(5): p. 608-10. Chemical & Physical Properties Molecular Formula C21H26O2 Exact Mass 310.193268 PSA 37.30000 Index of Refraction 1.588 InChIKey SIGSPDASOTUPFS-XUDSTZEESA-N
Transport InfoProduct name: Purity: 98.0%
MSDS Transport InfoModule 14. Shipping information 14.1 UN dangerous goods number European Land Transport Dangerous Regulations: -International Maritime Dangerous Regulations: -International Air Transport Dangerous Regulations: - 14.2 Names specified by the United Nations (UN) European Land Transport Dangerous Regulations: Non-dangerous goods IMDG Code: Non-dangerous goods International air transport dangerous goods regulations: non-dangerous goods 14.3 Transport hazard categories European Land Transport Dangerous Regulations: -International Maritime Dangerous Regulations: -International Air Transport Dangerous Regulations: - 14.4 Package group European Land Transport Dangerous Regulations: -International Maritime Dangerous Regulations: -International Air Transport Dangerous Regulations: - 14.5 Environmental hazards European Land Transport Dangerous Regulations: No International Maritime Transport Dangerous Regulations Maritime Pollutants: No International Air Transport Risk Regulations: No 14.6 Special reminder to users No data available
Related Products in API & Advanced Intermediates
Gefitinib184475-35-22A-9010701
Gemcitabine95058-81-42A-9010704
Gemcitabine hydrochloride122111-03-92A-9010705
Gemifloxacin175463-14-62A-9010708
Gentamicin B36889-15-32A-9010715
Glibenclamide10238-21-82A-9010753
Glimepiride93479-97-12A-0202308
Glipizide29094-61-92A-9010756
Granisetron109889-09-02A-9010779
Hydrocortisone50-23-72A-9010867
Browse all API & Advanced Intermediates products »
Contact Us

Phone:

630-322-8886

630-322-8887

Email:

[email protected]

Office Locations:

Chicago, IL, USA

San Francisco, CA, USA